Unichem Laboratories Limited (NSE:UNICHEMLAB)

Market Cap	43.62B
Revenue (ttm)	19.03B
Net Income (ttm)	-289.04M
Shares Out	n/a
EPS (ttm)	-4.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,930
Average Volume	74,153
Open	647.90
Previous Close	640.35
Day's Range	614.00 - 648.05
52-Week Range	501.00 - 937.95
Beta	0.22
RSI	44.05
Earnings Date	May 22, 2025

About Unichem Laboratories

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1944
• Employees: 2,875
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: UNICHEMLAB

Financial Performance

In 2023, Unichem Laboratories's revenue was 17.05 billion, an increase of 26.94% compared to the previous year's 13.43 billion. Losses were -704.74 million, -65.15% less than in 2022.